Avidity Partners Management LP Context Therapeutics Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 7,477,200 shares of CNTX stock, worth $6.06 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
7,477,200
Previous 7,417,155
0.81%
Holding current value
$6.06 Million
Previous $14.5 Million
49.08%
% of portfolio
0.84%
Previous 0.89%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$11.9 Million2.18% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.01 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.01 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.15 Million2.69% of portfolio
-
Great Point Partners LLC Greenwich, CT4.68MShares$3.79 Million3.06% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $12.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...